In the tumor microenvironment, increased MOR expression indicated decreased PD-L1 expression on cancer cells and decreased CD8+ T cell infiltrations, demonstrating poor response to PD-L1 therapy (Figure 4). This evidence concerns the gene CD8A and neoplasm.